Skip to main content
P

Pyure

Pyure offers advanced air and surface purification systems that generate hydroxyls to neutralize airborne pathogens, VOCs, and odors. Their technology safely operates continuously in occupied spaces, providing continuous sanitization without harming people, animals, or plants.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Indoor environments often harbor pathogens, volatile organic compounds (VOCs), and persistent odors that compromise air quality and occupant well-being. Traditional air purification methods may be insufficient or introduce harmful byproducts, failing to address both airborne and surface contaminants effectively.

Solution

Pyure provides advanced air and surface purification systems that leverage a technology mimicking natural sunlight to generate hydroxyls. These hydroxyls act as powerful organic oxidants, dispersing throughout indoor spaces to neutralize pathogens, VOCs, and odors. The systems are designed for continuous operation in occupied environments without degrading materials or harming people, animals, or plants. Pyure offers scalable solutions, including portable units and integrated in-duct systems, to address the specific air quality needs of diverse commercial and industrial settings.

Target Audience

Pyure targets commercial and industrial markets including healthcare, hospitality, food processing, education, and general commercial spaces that require robust indoor air quality management.

Features

  • Hydroxyl generation technology that replicates natural sunlight for indoor sanitization.
  • Continuous operation in occupied spaces with no need for evacuation.
  • Safe for use around people, animals, and plants, producing natural oxidant levels.
  • Effective in reducing airborne and surface bacteria, mold, viruses, and VOCs.
  • Does not degrade materials such as plastics, rubber, or fabrics.
  • Available in portable units for flexible deployment and in-duct units for integrated HVAC solutions.
  • Proven efficacy against a range of pathogens including MS2 bacteriophage, Phi-X174 bacteriophage, Staphylococcus epidermidis, Erwinia herbicola, and Aspergillus niger.
  • Supported by scientific studies and toxicity reports, including FDA 510k submissions.
This profile is AI-generated and may contain inaccuracies.